12:00 AM
Aug 07, 2006
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Oxygent perflubron: Phase II ongoing

The German Ethics Committee voted against letting ALLP start a 65-patient Phase II trial to prevent POI resulting from hypoxia during...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >